在个性化医疗时代治疗慢性淋巴细胞白血病的方法

María Del Mar Sánchez Suárez1, Alicia Martín Roldán1, Carolina Alarcón-Payer1

  • 1Servicio de Farmacia, Hospital Universitario Virgen de las Nieves, 18014 Granada, Granada, Spain.

Pharmaceutics
|January 23, 2024
PubMed
概括

由于遗传异质性,慢性淋巴细胞白血病 (CLL) 的个性化治疗至关重要. 根据个体遗传特征 (包括TP53突变) 量身定制疗法,可以提高疗效和治疗结果.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K